ARCT
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Arcturus Therapeutics reports interim Phase 2 results in OTC deficiency and introduces its next-generation LUNAR 2.0 mRNA delivery platformSep 23, 2026
- Arcturus Therapeutics will present Phase 2 clinical data for ornithine transcarbamylase deficiency and provide an update on its mRNA liver therapeutics platformSep 19, 2026
- Arcturus Therapeutics announces positive interim Phase 2 multiple dose data for OTC deficiency programJul 1, 2025